Jiaji Jiang

2.1k total citations
56 papers, 1.2k citations indexed

About

Jiaji Jiang is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Jiaji Jiang has authored 56 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Epidemiology, 45 papers in Hepatology and 5 papers in Molecular Biology. Recurrent topics in Jiaji Jiang's work include Hepatitis B Virus Studies (43 papers), Hepatitis C virus research (37 papers) and Liver Disease Diagnosis and Treatment (36 papers). Jiaji Jiang is often cited by papers focused on Hepatitis B Virus Studies (43 papers), Hepatitis C virus research (37 papers) and Liver Disease Diagnosis and Treatment (36 papers). Jiaji Jiang collaborates with scholars based in China, United States and France. Jiaji Jiang's co-authors include Yueyong Zhu, Jinlin Hou, Qin Ning, Meifang Han, Jing Dong, Deming Tan, Yongtao Sun, Didier Samuel, Su Lin and Hong Tang and has published in prestigious journals such as PLoS ONE, Journal of Virology and Biochemical and Biophysical Research Communications.

In The Last Decade

Jiaji Jiang

56 papers receiving 1.2k citations

Peers

Jiaji Jiang
Wen‐Yu Chang Taiwan
Etsuko Iio Japan
M Yoshiba Japan
Kentaro Yoshioka Japan
Ming‐Yuh Hsieh Taiwan
Martin‐Walter Welker Germany
Kei Fujiwara Japan
Simon H. Bridge United Kingdom
Haruki Komatsu Japan
Wen‐Yu Chang Taiwan
Jiaji Jiang
Citations per year, relative to Jiaji Jiang Jiaji Jiang (= 1×) peers Wen‐Yu Chang

Countries citing papers authored by Jiaji Jiang

Since Specialization
Citations

This map shows the geographic impact of Jiaji Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiaji Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiaji Jiang more than expected).

Fields of papers citing papers by Jiaji Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiaji Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiaji Jiang. The network helps show where Jiaji Jiang may publish in the future.

Co-authorship network of co-authors of Jiaji Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Jiaji Jiang. A scholar is included among the top collaborators of Jiaji Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiaji Jiang. Jiaji Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zheng, Qi, Xueping Yu, Airong Hu, et al.. (2024). Determining optimal ALT cut‐off values for predicting significant hepatic histological changes in patients with normal ALT in the grey zone of chronic hepatitis B virus infection. Alimentary Pharmacology & Therapeutics. 59(5). 692–704. 1 indexed citations
2.
Ye, Xiang‐Yang, Hui‐Ming Lin, Shuo Lin, et al.. (2023). Development a novel nomogram model for predicting significant hepatic histological changes in chronic hepatitis B virus carriers. Journal of Medical Virology. 95(7). e28943–e28943. 2 indexed citations
3.
Jiang, Jiaji, et al.. (2023). [Short-term efficacy of empagliflozin in children with glycogen storage disease type Ⅰb].. PubMed. 61(6). 515–519. 2 indexed citations
4.
Huang, Lingling, Xueping Yu, Huan Li, et al.. (2023). Liver Stiffness Measurement can Predict Liver Inflammation in Chronic Hepatitis B Patients with Normal Alanine Transaminase. Journal of Clinical and Translational Hepatology. 0(0). 0–0. 2 indexed citations
5.
Li, Yanan, et al.. (2022). Gut microbiota of hepatitis B virus-infected patients in the immune-tolerant and immune-active phases and their implications in metabolite changes. World Journal of Gastroenterology. 28(35). 5188–5202. 9 indexed citations
6.
Yu, Xueping, et al.. (2021). Effect of liver inflammation on accuracy of FibroScan device in assessing liver fibrosis stage in patients with chronic hepatitis B virus infection. World Journal of Gastroenterology. 27(7). 641–653. 25 indexed citations
7.
Wu, Di, Meifang Han, Yong‐Ping Chen, et al.. (2019). Sequential combination therapy with interferon, interleukin-2 and therapeutic vaccine in entecavir-suppressed chronic hepatitis B patients: the Endeavor study. Hepatology International. 13(5). 573–586. 34 indexed citations
8.
Huang, Rui, Huiying Rao, Jia Shang, et al.. (2018). A cross-sectional assessment of health-related quality of life in Chinese patients with chronic hepatitis c virus infection with EQ-5D. Health and Quality of Life Outcomes. 16(1). 124–124. 32 indexed citations
9.
Zhang, Wenhong, Dazhi Zhang, Xiaoguang Dou, et al.. (2018). Consensus on Pegylated Interferon Alpha in Treatment of Chronic Hepatitis B. Journal of Clinical and Translational Hepatology. 6(1). 1–10. 20 indexed citations
10.
Dong, Jing, et al.. (2016). Noninvasive models for assessment of liver fibrosis in patients with chronic hepatitis B virus infection. World Journal of Gastroenterology. 22(29). 6663–6663. 22 indexed citations
11.
Dong, Jing, et al.. (2016). Ceruloplasmin, a reliable marker of fibrosis in chronic hepatitis B virus patients with normal or minimally raised alanine aminotransferase. World Journal of Gastroenterology. 22(43). 9586–9586. 13 indexed citations
12.
Zhang, Jiemin, et al.. (2016). A Retrospective Study on the Significance of Liver Biopsy and Hepatitis B Surface Antigen in Chronic Hepatitis B Infection. Medicine. 95(8). e2503–e2503. 12 indexed citations
13.
Lin, Su, Ming-Fang Wang, Zhiyuan Weng, et al.. (2015). Interleukin-6 as an early diagnostic marker for bacterial sepsis in patients with liver cirrhosis. Journal of Critical Care. 30(4). 732–738. 35 indexed citations
14.
Lin, Su, Ming-Fang Wang, Yueyong Zhu, et al.. (2015). Hemorrhagic Complications Following Abdominal Paracentesis in Acute on Chronic Liver Failure. Medicine. 94(49). e2225–e2225. 40 indexed citations
15.
Lin, Binbin, Yueyong Zhu, Jing Chen, et al.. (2014). Alpha-fetoprotein level as a biomarker of liver fibrosis status: a cross-sectional study of 619 consecutive patients with chronic hepatitis B. BMC Gastroenterology. 14(1). 145–145. 35 indexed citations
16.
Ning, Qin, Meifang Han, Yongtao Sun, et al.. (2014). Switching from entecavir to PegIFN alfa-2a in patients with HBeAg-positive chronic hepatitis B: A randomised open-label trial (OSST trial). Journal of Hepatology. 61(4). 777–784. 174 indexed citations
17.
Lin, Su, Zhiyuan Weng, Jing Xu, et al.. (2013). A study of multiple biliary hamartomas based on 1697 liver biopsies. European Journal of Gastroenterology & Hepatology. 25(8). 948–952. 16 indexed citations
18.
19.
Zhu, Yueyong, et al.. (2012). Small hepatitis B surface antigen interacts with and modulates enoyl–coenzyme A hydratase expression in hepatoma cells. Archives of Virology. 158(5). 1065–1070. 7 indexed citations
20.
Zeng, G., Z. Wang, Si Wen, et al.. (2005). Geographic distribution, virologic and clinical characteristics of hepatitis B virus genotypes in China. Journal of Viral Hepatitis. 12(6). 609–617. 129 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wen‐Yu Chang Breakdown of academic impact, for papers by Etsuko Iio Breakdown of academic impact, for papers by M Yoshiba Breakdown of academic impact, for papers by Kentaro Yoshioka Breakdown of academic impact, for papers by Ming‐Yuh Hsieh Breakdown of academic impact, for papers by Martin‐Walter Welker Breakdown of academic impact, for papers by Kei Fujiwara Breakdown of academic impact, for papers by Simon H. Bridge Breakdown of academic impact, for papers by Haruki Komatsu
Rankless by CCL
2026